Dimensional Fund Advisors’s Ginkgo Bioworks DNA Stock Holding History

Dimensional Fund Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.05M	Buy	471,921 +120,721	+34%	+$984K	﹤0.01%	2447
2026 Q2	$3.48M	Buy	351,200 +224,152	+176%	+$1.87M	﹤0.01%	2619
2026 Q1	$779K	Buy	127,048 +24,434	+24%	+$203K	﹤0.01%	2884
2025 Q4	$853K	Buy	102,614 +89,298	+671%	+$962K	﹤0.01%	2882
2025 Q3	$194K	Buy	13,316 +519	+4%	+$6.21K	﹤0.01%	3124
2025 Q2	$144K	Hold	12,797	–	–	﹤0.01%	3150
2025 Q1	$72.9K	Buy	+12,797	New	+$130K	﹤0.01%	3235

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Dimensional Fund Advisors's DNA Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Ginkgo Bioworks (DNA) stake by 34% in Q3 2026, buying an estimated $984K and bringing the position to 471,921 shares worth $6.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Dimensional Fund Advisors first reported a position in DNA in Q1 2025 and has held it in 7 quarters since. 64 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

Dimensional Fund Advisors held 471,921 shares of Ginkgo Bioworks worth $6.05M as of Q3 2026.
Dimensional Fund Advisors bought 120,721 Ginkgo Bioworks shares in Q3 2026, an estimated $984K.
Ginkgo Bioworks made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2447 holding.
Dimensional Fund Advisors first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 7 quarters since.
64 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.